Opioid knowledge and perceptions among Hispanic/Latino residents in Los Angeles

References

• Singh GK, Kim IE, Girmay M, et al. Opioid epidemic in the United States: empirical trends, and a literature review of social determinants and epidemiological, pain management, and treatment patterns. Int J MCH Aids. 2019;8(2):89–100.
   PubMedGoogle Scholar
• Hudgins JD, Porter JJ, Monuteaux MC, Bourgeois FT. Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study. PLoS Med. 2019;16(11):e1002922. Published 2019 Nov 5.
   PubMed Web of Science ®Google Scholar
• Zeledon I, West A, Antony V, et al. Statewide collaborative partnerships among American Indian and Alaska Native (AI/AN) communities in California to target the opioid epidemic: preliminary results of the Tribal Medication Assisted Treatment (MAT) key informant needs assessment. J Subst Abuse Treat. 2020;108:9–19.
   PubMed Web of Science ®Google Scholar
• Lippold KM, Jones CM, Olsen EO, Giroir BP. Racial/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged ≥18 years in metropolitan areas – United States, 2015–2017. MMWR Morb Mortal Wkly Rep. 2019;68(43):967–973. Published 2019 Nov 1.
   PubMed Web of Science ®Google Scholar
• Bergman BG, Ashford RD, Kelly JF. Attitudes toward opioid use disorder medications: results from a U.S. national study of individuals who resolved a substance use problem. Exp Clin Psychopharmacol. 2020;28(4):449–461.
   PubMed Web of Science ®Google Scholar
• Brenes F, Henriquez F. Hispanics, addictions, and the opioid epidemic: brief report. Hisp Health Care Int. 2020;18(1):40–43. 1540415319888437.
   PubMedGoogle Scholar
• Evans EA, Yoo C, Huang D, Saxon AJ, Hser YI. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: results from a multisite randomized trial of adults with opioid use disorder. J Subst Abuse Treat. 2019;106:19–28.
   PubMed Web of Science ®Google Scholar
• Hadland SE, Wharam JF, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. 2017;171(8):747–755.
   PubMed Web of Science ®Google Scholar
• Lapham G, Boudreau DM, Johnson EA, et al. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020;207:107732.
   PubMed Web of Science ®Google Scholar
• Rhee TG, Rosenheck RA. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States? Addiction. 2019;114(11):1992–1999.
   PubMed Web of Science ®Google Scholar
• Hser YI, Saxon AJ, Huang D, et al. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction. 2014;109(1):79–87.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Evans EA, Mooney LJ, et al. Correlates of long-term opioid abstinence after randomization to methadone versus buprenorphine/naloxone in a multi-site trial. J Neuroimmune Pharmacol. 2018;13(4):488–497.
   PubMed Web of Science ®Google Scholar
• Beyene KA, Sheridan J, Aspden T. Prescription medication sharing: a systematic review of the literature. Am J Public Health. 2014;104(4):e15–e26.
   PubMed Web of Science ®Google Scholar
• Ford JA, Pomykacz C, Szalewski A, Esteban McCabe S, Schepis TS. Friends and relatives as sources of prescription opioids for misuse among young adults: the significance of physician source and race/ethnic differences. Subst Abus. 2020;41(1):93–100.
   PubMed Web of Science ®Google Scholar
• Lewis ET, Cucciare MA, Trafton JA. What do patients do with unused opioid medications? Clin J Pain. 2014;30(8):654–662.
   PubMed Web of Science ®Google Scholar
• Kennedy-Hendricks A, Gielen A, McDonald E, McGinty EE, Shields W, Barry CL. Medication Sharing, Storage, and Disposal Practices for Opioid Medications Among US Adults. JAMA Intern Med. 2016;176(7):1027–1029.
   PubMed Web of Science ®Google Scholar
• Madden EF, Qeadan F. Racial inequities in U.S. naloxone prescriptions. Subst Abus. 2020;41(2):232–244.
   PubMed Web of Science ®Google Scholar
• Katzman JG, Greenberg NH, Takeda MY, Moya Balasch M. Characteristics of patients with opioid use disorder associated with performing overdose reversals in the community: an opioid treatment program analysis. J Addict Med. 2019;13(2):131–138.
   PubMed Web of Science ®Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
   Google Scholar
• Lincoln YS, Guba EG. Naturalistic Inquiry. Vol. 75. Thousand Oaks, CA: Sage; 2005.
   Google Scholar
• Strauss A, Corbin J. Basics of Qualitative Research. Vol. 15. Newbury Park, CA: Sage; 1990.
   Google Scholar
• Castro FG, Bautista TG, Mendieta MI, Ramirez SO, Heydarian NM, Hughes AS. Chapter 23. Systems contexts for designing culturally adapted prevention interventions. In: Schwartz SJ, Unger J, eds. The Oxford Handbook of Acculturation and Health. Oxford: Oxford University Press; 2017:411.
   Google Scholar
• Sorrell TR. Mexican traditional medicine: application of a traditional and complementary medicine system to improve opioid use treatment in Latinos. J Holist Nurs. 2020. doi:https://doi.org/10.1177/0898010120911540.
   Google Scholar
• Heyward J, Olson L, Sharfstein JM, Stuart EA, Lurie P, Alexander GC. Evaluation of the extended-release/long-acting opioid prescribing risk evaluation and mitigation strategy program by the US Food and Drug Administration: a review. JAMA Intern Med. 2020;180(2):301.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. 2017. Key Substance Use and Mental Health Indicators in the United States: Results from the SAMHSA. 2016 National Survey on Drug Use and Health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/
   Google Scholar
• Unger JB, Vos R, Wu J, et al. Locations of licensed and unlicensed cannabis retailers in California: a threat to health equity? Prevent Med Rep. 19:101165.
   PubMedGoogle Scholar
• Azagba S, Shan L, Manzione L, Qeadan F, Wolfson M. Trends in opioid misuse among marijuana users and non-users in the U.S. from 2007–2017. IJERPH. 2019;16(22):4585.
   Google Scholar
• Valdivieso-Mora E, Peet CL, Garnier-Villarreal M, Salazar-Villanea M, Johnson DK. A systematic review of the relationship between familism and mental health outcomes in Latino population. Front Psychol. 2016;7:1632.
   PubMed Web of Science ®Google Scholar
• SAMHSA. Manual de instrucción de SAMHSA para la prevención de sobredosis de opioides. 2018. https://store.samhsa.gov/system/files/sma18-4742spanish.pdf.
   Google Scholar